We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
14 hedge funds and large institutions have $649K invested in Atossa Therapeutics in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.18% less ownership
Funds ownership: 0.36% → 0.19% (-0.18%)
15% less capital invested
Capital invested by funds: $765K → $649K (-$116K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
4
Calls
$43K
Puts
–
Net Calls
+$43K
Net Calls Change
+$43K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$137K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$114K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$27.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.01K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$801 |